Clinical trial
A Randomized Phase Ⅱ/Ⅲ Trial of Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
NCT03600831 is registered in ClinicalTrials.gov with Huai'an First People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase Ⅱ/Ⅲ Trial of Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
- Lead sponsor
- Huai'an First People's Hospital
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- August 20, 2018
- Completion date
- December 31, 2023
- Enrollment
- 434 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.